'Thoughtless Interference': HCG CMD On Cancer Drug Price Curbs

HCG's Ajai Kumar says the MRP can be cut, but the 30% trade margin cap on non-scheduled cancer drugs could keep new treatments from Indian patients.
Read the full story on NDTV Profit Opens ndtvprofit.com in a new tab
This is a short summary of a story published by NDTV Profit, shown with a link to the original. The full story, photo and reporting belong to NDTV Profit.












